Drug Profile
Insulin B-chain vaccine - Orban Biotech
Alternative Names: IBC-VS01Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Orban Biotech
- Class Antihyperglycaemics; Diabetes mellitus vaccines; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Type 1 diabetes mellitus
Most Recent Events
- 04 Feb 2016 No recent reports on development identified - Phase-I for Type-1 diabetes mellitus in USA (IM)
- 04 Feb 2016 No recent reports on development identified - Preclinical for Type-1 diabetes mellitus (Combination therapy) in USA (IM)
- 05 Aug 2011 Preclinical trials in Type-1 diabetes mellitus in USA (combination therapy) (IM)